Table: Aska Pharmaceutical Holdings - 9-MTH group results

ASKA Pharmaceutical Holdings

02/02/2026 06:31

Feb 2 (Reuters)- 
             Aska Pharmaceutical Holdings Co., Ltd. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Dec 31, 2025        Dec 31, 2024     Mar 31, 2026 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             54.49               49.93            71.00    
                 (+9.1 pct)          (+2.3 pct)       (+10.7 pct) 
  Operating          4.91                5.50             6.00    
                 (-10.6 pct)         (-0.6 pct)       (+12.5 pct) 
  Recurring          4.85                5.45             6.00    
                 (-10.9 pct)         (-3.3 pct)       (+17.5 pct) 
  Net                3.90                4.10             5.00    
                 (-4.7 pct)          (-36.5 pct)      (-2.0 pct)  
  EPS            137.59 yen          144.59 yen       176.22 yen  
  Ann Div                             55.00 yen        55.00 yen  
  -Q2 div         27.00 yen           25.00 yen                   
  -Q4 div                             30.00 yen        28.00 yen  
  
  NOTE - Aska Pharmaceutical Holdings Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4886.T